Targeting liver X receptors in human health: Deadlock or promising trail?

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 2, 2011, Pages 219-232

  Viennois, Emilie ^a,b,c   Pommier, Aurélien J C ^a,b,c   Mouzat, Kévin ^d   Oumeddour, Abdelkader ^a,b,c,e   El Hajjaji, Fatim Zohra ^a,b,c   Dufour, Julie ^a,b,c   Caira, Françoise ^a,b,c   Volle, David H ^a,b,c   Baron, Silvère ^a,b,c   Lobaccaro, Jean Marc A ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

^c CRNH AUVERGNE   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

^e BADJI MOKHTAR UNIVERSITY   (Algeria)

Author keywords

cancer; human diseases; LXR; nuclear receptors; pharmacology; reproduction

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; BILE ACID; CHOLESTEROL; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ANTAGONIST; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BILE ACID SYNTHESIS; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG MECHANISM; FATTY ACID METABOLISM; FEMALE GENITAL SYSTEM; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; IMMUNITY; LIPID METABOLISM; MALE GENITAL SYSTEM; NEOPLASM; NONHUMAN; REVIEW; SKIN DISEASE; STEROIDOGENESIS;

ALZHEIMER DISEASE; ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; DIABETES MELLITUS; FEMALE; HUMANS; LIGANDS; MALE; MICE; MOLECULAR TARGETED THERAPY; NEOPLASMS; ORPHAN NUCLEAR RECEPTORS; PROTEIN ISOFORMS; REPRODUCTION; SKIN DISEASES;

EID: 78651354102     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2011.547853     Document Type: Review

References (111)

1. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000;16:459-81
2. Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9:1033-45
3. Janowski BA, Willy PJ, Devi TR, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-31
4. Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002;277:18793-800
5. Nuclear Receptors Signaling Atlas. Bethesda, MD: Nuclear Receptors Signaling Atlas consortium, 2003 - 2010 Available from: www.nursa.org [Last accessed 14 December 2010]
6. Souidi M, Dubrac S, Parquet M, et al. Oxysterols: metabolism, biological role and associated diseases. Gastroenterol Clin Biol 2004;28:279-93
7. Lehmann JM, Kliewer SA, Moore LB, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137-40
8. Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 2007;28:91-106
9. Hu X, Li S, Wu J, et al. Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol 2003;17:1019-26
10. Lazar MA. Nuclear receptor corepressors. Nucl Recept Signal 2003;1:e001
11. Lee S, Lee J, Lee SK, et al. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol Endocrinol 2008;22:1312-19
12. Svensson S, Ostberg T, Jacobsson M, et al. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J 2003;22:4625-33
13. Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000;80:361-554
14. Bjorkhem I. Are side-chain oxidized oxysterols regulators also in vivo? J Lipid Res 2009;50(Suppl):S213-18
15. Yang C, McDonald JG, Patel A, et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 2006;281:27816-26
16. Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000;65:423-7
17. Ondeyka JG, Jayasuriya H, Herath KB, et al. Steroidal and triterpenoidal fungal metabolites as ligands of liver X receptors. J Antibiot (Tokyo) 2005;58:559-65
18. Jayasuriya H, Herath KB, Ondeyka JG, et al. Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. J Nat Prod 2005;68:1247-52
19. Huang TH, Razmovski-Naumovski V, Salam NK, et al. A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum. Biochem Pharmacol 2005;70:1298-308
20. Li X, Yeh V, Molteni V. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009). Expert Opin Ther Pat 2010;20:535-62
21. Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831-8
22. Collins JL, Fivush AM, Watson MA, et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45:1963-6
23. Houck KA, Borchert KM, Hepler CD, et al. T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 2004;83:184-7
24. Shenoy SD, Spencer TA, Mercer-Haines NA, et al. CYP3A induction by liver X receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos 2004;32:66-71
25. Mitro N, Vargas L, Romeo R, et al. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 2007;581:1721-6
26. Joseph SB, Laffitte BA, Patel PH, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002;277:11019-25
27. Lund EG, Peterson LB, Adams AD, et al. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Biochem Pharmacol 2006;71:453-63
28. Bradley MN, Hong C, Chen M, et al. Ligand activation of LXRbeta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRalpha and apoE. J Clin Invest 2007;117:2337-46
29. Kaneko E, Matsuda M, Yamada Y, et al. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem 2003;278:36091-8
30. Yasuda T, Grillot D, Billheimer JT, et al. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30:781-6
31. Katz A, Udata C, Ott E, et al. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 2009;49:643-9
32. DiBlasio-Smith EA, Arai M, Quinet EM, et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med 2008;6:59
33. Hu B, Unwalla RJ, Goljer I, et al. Identification of phenylsulfone- substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist. J Med Chem 2010;53:3296-304
34. Yoshikawa T, Shimano H, Yahagi N, et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002;277:1705-11
35. Ou J, Tu H, Shan B, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001;98:6027-32
36. Qin Y, Dalen KT, Gustafsson JA, et al. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c. Biochim Biophys Acta 2009;1791:140-7
37. Herath K, Jayasuriya H, Ondeyka JG, et al. Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. J Nat Prod 2005;68:617-9
38. Tamehiro N, Sato Y, Suzuki T, et al. Riccardin C: a natural product that functions as a liver X receptor (LXR) alpha agonist and an LXRbeta antagonist. FEBS Lett 2005;579:5299-304
39. Janowski BA, Grogan MJ, Jones SA, et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 1999;96:266-71
40. Thomas J, Bramlett KS, Montrose C, et al. A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha) versus liver X receptor. J Biol Chem 2003;278:2403-10
41. Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999;284:757-60
42. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRalpha. Cell 1998;93:693-704
43. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001;262:257-65
44. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45
45. Hubacek JA, Berge KE, Cohen JC, et al. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001;18:359-60
46. Costet P, Luo Y, Wang N, et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/ retinoid X receptor. J Biol Chem 2000;275:28240-5
47. Kennedy MA, Venkateswaran A, Tarr PT, et al. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem 2001;276:39438-47
48. Laffitte BA, Repa JJ, Joseph SB, et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 2001;98:507-12
49. Repa JJ, Liang G, Ou J, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-30
50. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007;282:743-51
51. Denechaud PD, Bossard P, Lobaccaro JM, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008;118:956-64
52. Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 2003;100:5419-24
53. Efanov AM, Sewing S, Bokvist K, et al. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004;53(Suppl 3):S75-8
54. Ogihara T, Chuang JC, Vestermark GL, et al. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 2010;285:5392-404
55. Gerin I, Dolinsky VW, Shackman JG, et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005;280:23024-31
56. Zitzer H, Wente W, Brenner MB, et al. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 2006;147:3898-905
57. Cummins CL, Volle DH, Zhang Y, et al. Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 2006;116:1902-12
58. Volle DH, Mouzat K, Duggavathi R, et al. Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol 2007;21:1014-27
59. Robertson KM, Schuster GU, Steffensen KR, et al. The liver X receptor-beta is essential for maintaining cholesterol homeostasis in the testis. Endocrinology 2005;146:2519-3
60. Mouzat K, Volat F, Baron S, et al. Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice. Endocrinology 2009;150:3369-75
61. Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003;9:213-9
62. Castrillo A, Joseph SB, Marathe C, et al. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 2003;278:10443-9
63. Castrillo A, Joseph SB, Vaidya SA, et al. Crosstalk between LXR and toll-likereceptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003;12:805-16
64. Fontaine C, Rigamonti E, Pourcet B, et al. The nuclear receptor Rev-erbalpha is a liver X receptor (LXR) target gene driving a negative feedback loop on select LXR-induced pathways in human macrophages. Mol Endocrinol 2008;22:1797-811
65. Ogawa D, Stone JF, Takata Y, et al. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res 2005;96:e59-67
66. Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002;99:7604-9
67. Lo Sasso G, Murzilli S, Salvatore L, et al. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 2010;12:187-93
68. Quinet EM, Basso MD, Halpern AR, et al. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res 2009;50:2358-70
69. Dave VP, Kaul D, Sharma Y, et al. Functional genomics of blood cellular LXR-alpha gene in human coronary heart disease. J Mol Cell Cardiol 2009;46:536-44
70. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93:S9-S30
71. Cao G, Liang Y, Broderick CL, et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 2003;278:1131-6
72. Kase ET, Wensaas AJ, Aas V, et al. Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 2005;54:1108-15
73. Dahlman I, Nilsson M, Jiao H, et al. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics 2006;16:881-9
74. Martin M, Dotti CG, Ledesma MD. Brain cholesterol in normal and pathological aging. Biochim Biophys Acta 2010;1801:934-44
75. Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000;356:1627-31
76. Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43
77. Koldamova RP, Lefterov IM, Staufenbiel M, et al. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimers disease. J Biol Chem 2005;280:4079-88
78. Zelcer N, Khanlou N, Clare R, et al. Attenuation of neuroinflammation and Alzheimers disease pathology by liver X receptors. Proc Natl Acad Sci USA 2007;104:10601-6
79. Fitz NF, Cronican A, Pham T, et al. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci 2010;30:6862-72
80. Wang Y, Rogers PM, Stayrook KR, et al. The selective Alzheimers disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol Pharmacol 2008;74:1716-21
81. Adighibe O, Arepalli S, Duckworth J, et al. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimers disease. Neurobiol Aging 2006;27:1431-4
82. Infante J, Rodriguez-Rodriguez E, Mateo I, et al. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimers disease risk. Neurobiol Aging 2010;31:710-14
83. Komuves LG, Schmuth M, Fowler AJ, et al. Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol 2002;118:25-34
84. Hanley K, Ng DC, He SS, et al. Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol 2000;114:545-53
85. Jiang YJ, Lu B, Kim P, et al. Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J Lipid Res 2006;47:2248-58
86. Chang KC, Shen Q, Oh IG, et al. Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Mol Endocrinol 2008;22:2407-19
87. Hatano Y, Man MQ, Uchida Y, et al. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/d (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010;125:160-9 e1-5
88. Steffensen KR, Robertson K, Gustafsson JA, et al. Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol Cell Endocrinol 2006;256:9-16
89. Drouineaud V, Sagot P, Garrido C, et al. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod 2007;13:373-9
90. Marceau G, Volle DH, Gallot D, et al. Placental expression of the nuclear receptors for oxysterols LXRalpha and LXRbeta during mouse and human development. Anat Rec A Discov Mol Cell Evol Biol 2005;283:175-81
91. Henry-Berger J, Mouzat K, Baron S, et al. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR. Biol Reprod 2008;78:968-75
92. Mouzat K, Prodhomme M, Volle DH, et al. Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem 2007;282:4693-701
93. Frenoux JM, Vernet P, Volle DH, et al. Nuclear oxysterol receptors, LXRs, are involved in the maintenance of mouse caput epididymidis structure and functions. J Mol Endocrinol 2004;33:361-75
94. Saez F, Chabory E, Cadet R, et al. Liver X receptors and epididymal epithelium physiology. Asian J Androl 2007;9:574-82
95. Ouvrier A, Cadet R, Vernet P, et al. LXR and ABCA1 control cholesterolhomeostasis in the proximal mouse epididymis in a cell-specific manner. J Lipid Res 2009;50:1766-75
96. Rough JJ, Monroy MA, Yerrum S, et al. Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res 2010;3:13
97. Vedin LL, Lewandowski SA, Parini P, et al. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009;30:575-9
98. Kim KH, Yoon JM, Choi AH, et al. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. Mol Endocrinol 2009;23:466-74
99. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64
100. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232-40
101. Watanabe M, Nakayama T, Shiraishi T, et al. Comparative studies of prostate cancer in Japan versus the United States. A review. Urol Oncol 2000;5:274-83
102. Magura L, Blanchard R, Hope B, et al. Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control 2008;19:1259-66
103. Platz EA, Leitzmann MF, Visvanathan K, et al. Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006;98:1819-25
104. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol 2005;162:318-25
105. Fukuchi J, Kokontis JM, Hiipakka RA, et al. Antiproliferative effect of liver Xreceptor agonists on LNCaP human prostate cancer cells. Cancer Res 2004;64:7686-9
106. Pommier AJ, Alves G, Viennois E, et al. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene2010;29:2712-23
107. Fukuchi J, Hiipakka RA, Kokontis JM, et al. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 2004;64:7682-5
108. Kim HJ, Andersson LC, Bouton D, et al. Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc Natl Acad Sci USA 2009;106:558-63
109. Farnegardh M, Bonn T, Sun S, et al. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J Biol Chem 2003;278:38821-8
110. Poujol N, Wurtz JM, Tahiri B, et al. Specific recognition of androgens by their nuclear receptor. A structurefunction study. J Biol Chem 2000;275:24022-31
111. Mouzat K, Alves G, Pommier A, et al. Nuclear liver X receptors are involved in the biology of reproduction. Med Sci (Paris) 2009;25:141-4